Boc-D-aspartic acid β-cyclohexyl ester
Need Assistance?
  • US & Canada:
    +
  • UK: +

Boc-D-aspartic acid β-cyclohexyl ester

* Please kindly note that our products are not to be used for therapeutic purposes and cannot be sold to patients.

Category
BOC-Amino Acids
Catalog number
BAT-004525
CAS number
112898-18-7
Molecular Formula
C15H25NO6
Molecular Weight
315.40
Boc-D-aspartic acid β-cyclohexyl ester
IUPAC Name
(2R)-4-cyclohexyloxy-2-[(2-methylpropan-2-yl)oxycarbonylamino]-4-oxobutanoic acid
Synonyms
Boc-D-Asp(OcHex)-OH; (R)-2-((tert-Butoxycarbonyl)amino)-4-(cyclohexyloxy)-4-oxobutanoic acid
Appearance
White to off-white powder
Purity
≥ 99% (HPLC)
Density
1.18±0.1 g/cm3(Predicted)
Melting Point
90-100 °C
Boiling Point
487.2±40.0 °C(Predicted)
Storage
Store at 2-8°C
InChI
InChI=1S/C15H25NO6/c1-15(2,3)22-14(20)16-11(13(18)19)9-12(17)21-10-7-5-4-6-8-10/h10-11H,4-9H2,1-3H3,(H,16,20)(H,18,19)/t11-/m1/s1
InChI Key
NLPQIWFEEKQBBN-LLVKDONJSA-N
Canonical SMILES
CC(C)(C)OC(=O)NC(CC(=O)OC1CCCCC1)C(=O)O

Boc-D-aspartic acid β-cyclohexyl ester, a chemical compound commonly employed in peptide synthesis and pharmaceutical research, finds diverse applications. Here are four key applications:

Peptide Synthesis: Serving as a safeguarded amino acid derivative in the solid-phase synthesis of peptides, Boc-D-aspartic acid β-cyclohexyl ester plays a crucial role in preventing undesirable side reactions and racemization during the elongation of the peptide chain. This leads to the efficient production of high-purity peptides, which are indispensable for both research and therapeutic endeavors.

Drug Development: In the realm of drug discovery, Boc-D-aspartic acid β-cyclohexyl ester emerges as a valuable tool for generating peptide-based drug candidates. Its robust stability and ease of integration into peptide sequences render it an optimal choice for designing innovative therapeutics. Researchers harness the compound’s properties to explore structure-activity relationships and fine-tune pharmacological characteristics, shaping the landscape of pharmaceutical innovation.

Bioconjugation: Widely utilized in the realm of bioconjugation, Boc-D-aspartic acid β-cyclohexyl ester plays a pivotal role in crafting bioconjugates that link peptides with other bioactive molecules or diagnostic agents. This process enables targeted delivery of therapeutic agents and enhances the specificity of diagnostic tools, fostering the development of advanced biopharmaceuticals and cutting-edge medical diagnostics.

Proteomic Research: Within the realm of proteomics, Boc-D-aspartic acid β-cyclohexyl ester is instrumental in synthesizing custom peptides tailored for mass spectrometry analysis. These peptides can be outfitted with isotopic labels or other tags to delve into protein expression, interactions, and modifications. Such applications are instrumental in unraveling the dynamics of the proteome and pinpointing biomarkers for a myriad of diseases.

1.A colorimetric assay that specifically measures Granzyme B proteolytic activity: hydrolysis of Boc-Ala-Ala-Asp-S-Bzl.
Hagn M1, Sutton VR2, Trapani JA3. J Vis Exp. 2014 Nov 28;(93):e52419. doi: 10.3791/52419.
The serine protease Granzyme B (GzmB) mediates target cell apoptosis when released by cytotoxic T lymphocytes (CTL) or natural killer (NK) cells. GzmB is the most studied granzyme in humans and mice and therefore, researchers need specific and reliable tools to study its function and role in pathophysiology. This especially necessitates assays that do not recognize proteases such as caspases or other granzymes that are structurally or functionally related. Here, we apply GzmB's preference for cleavage after aspartic acid residues in a colorimetric assay using the peptide thioester Boc-Ala-Ala-Asp-S-Bzl. GzmB is the only mammalian serine protease capable of cleaving this substrate. The substrate is cleaved with similar efficiency by human, mouse and rat GzmB, a property not shared by other commercially available peptide substrates, even some that are advertised as being suitable for this purpose. This protocol is demonstrated using unfractionated lysates from activated NK cells or CTL and is also suitable for recombinant proteases generated in a variety of prokaryotic and eukaryotic systems, provided the correct controls are used.
2.Asymmetric synthesis of trans-2,3-piperidinedicarboxylic acid and trans-3,4-piperidinedicarboxylic acid derivatives.
Xue CB1, He X, Roderick J, Corbett RL, Decicco CP. J Org Chem. 2002 Feb 8;67(3):865-70.
Asymmetric syntheses of (2S,3S)-3-(tert-butoxycarbonyl)-2-piperidinecarboxylic acid (1b), (3R,4S)-4-(tert-butoxycarbonyl)-3-piperidinecarboxylic acid (2b), and their corresponding N-Boc and N-Cbz protected analogues 8a,b and 17a,b are described. Enantiomerically pure 1b has been synthesized in five steps starting from L-aspartic acid beta-tert-butyl ester. Tribenzylation of the starting material followed by alkylation with allyl iodide using KHMDS produces the key intermediate 5a in a 6:1 diastereomeric excess. Upon hydroboration, the alcohol 6a is oxidized, and the resulting aldehyde 7 is subjected to a ring closure via reductive amination, providing 1b in an overall yield of 38%. Optically pure 2b has been synthesized beginning with N-Cbz-beta-alanine. The synthesis involves the induction of the first stereogenic center using Evans's chemistry and sequential LDA-promoted alkylations with tert-butyl bromoacetate and allyl iodide. Further elaboration by ozonolysis and reductive amination affords 2b in an overall yield of 28%.
3.Caspase-1 inhibitors abolish deleterious enhancement of COX-2 expression induced by HIV-1 gp120 in human neuroblastoma cells.
Corasaniti MT1, Bellizzi C, Russo R, Colica C, Amantea D, Di Renzo G. Toxicol Lett. 2003 Apr 4;139(2-3):213-9.
The human CHP100 neuroblastoma cell line has been shown to provide an useful in vitro model to elucidate the mechanisms underlying HIV-1 gp120 neurotoxicity. Here we report western blotting evidence demonstrating that exposure to a cytotoxic concentration of the viral coat protein up-regulates expression of the inducible isoform of cyclooxygenase (COX-2) in neuroblastoma cells and this seems to be due to the previously observed increase in secreted IL-1beta. In fact, here we show that acetyl-Tyr-Val-Ala-Asp-chloromethylketone (Ac-YVAD-CMK) and t-butoxycarbonyl-L-aspartic acid benzyl ester-chloromethylketone (Boc-Asp-(OBzl)-CMK), two inhibitors of Interleukin-1 Converting Enzyme (ICE; also referred to as caspase-1), abolish COX-2 expression enhanced by gp120 and consequent cell death. In addition, NS-398, a selective inhibitor of COX-2 activity, affords neuroprotection strengthening the role of COX-2 in the mechanisms of death. In conclusion, the present data support the notion that IL-1beta is the signal through which gp120 elevates COX-2 expression and the latter is strongly implicated in the mechanisms underlying cytotoxicity.
4.Synthesis of a new pi-deficient phenylalanine derivative from a common 1,4-diketone intermediate and study of the influence of aromatic density on prolyl amide isomer population.
Dörr A1, Lubell WD. Biopolymers. 2007;88(2):290-9.
Enantiopure (2S)-N-(Boc)-3-(6-methylpyridazinyl)alanine (14) has been synthesized to serve as a phenylalanine analog lacking significant pi-donor capability. Two approaches were developed to furnish the target compound from L-aspartic acid as chiral educt in respectively six and nine steps and 13% and 12% yields. In both routes, a key homoallylic ketone intermediate was synthesized by a copper-catalyzed cascade addition of vinylmagnesium bromide to a carboxylic ester. Dipeptide models Ac-Xaa-Pro-NHMe (21a-c) were prepared and the relative populations of prolyl cis- and trans-amide isomers were measured in chloroform, dimethylsulfoxide, and water by proton NMR spectroscopy in order to assess the significance of the electron density of the neighboring aromatic residue on the prolyl amide geometry.
Online Inquiry
Verification code
Inquiry Basket